Abciximab
| CAS No. | 143653-53-6 | Cat. No. | BCP30526 |
| Name | Abciximab | ||
| Synonyms | Abcixifiban；Reopro；c7E3 Fab; | ||
| Formula | C2101H3229N551O673S15 | M. Wt | 47455.4 g/mol |
| Description | Abciximab is a glycoprotein IIb/IIIa receptor antagonist and a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | Integrin | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.